Salud financiera de hoja de balance de Aspen Pharmacare Holdings
Salud financiera controles de criterios 5/6
Aspen Pharmacare Holdings tiene unos fondos propios totales de ZAR86.2B y una deuda total de ZAR28.8B, lo que sitúa su ratio deuda/fondos propios en 33.5%. Sus activos y pasivos totales son ZAR134.3B y ZAR48.0B respectivamente. Aspen Pharmacare Holdings El EBIT de la empresa es de ZAR8.9B, por lo que su ratio de cobertura de intereses es de 10.7. Su tesorería e inversiones a corto plazo ascienden a ZAR10.9B.
Información clave
42.2%
Ratio deuda-patrimonio
R36.12b
Deuda
| Ratio de cobertura de intereses | 8.4x |
| Efectivo | R11.60b |
| Patrimonio | R85.60b |
| Total pasivo | R53.69b |
| Activos totales | R139.29b |
Actualizaciones recientes sobre salud financiera
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Recent updates
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30Análisis de la situación financiera
Pasivos a corto plazo: APNLos activos a corto plazo (ZAR44.5B) de la empresa superan a sus pasivos a corto plazo (ZAR23.1B).
Pasivo a largo plazo: APNLos activos a corto plazo (ZAR44.5B) superan a sus pasivos a largo plazo (ZAR24.9B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: APN(20.8%) se considera satisfactoria.
Reducción de la deuda: APN ha pasado de 117.4% a 33.5% en los últimos 5 años.
Cobertura de la deuda: APN's debt is not well covered by operating cash flow (19.1%).
Cobertura de intereses: APNLos pagos de intereses de su deuda están bien cubiertos por el EBIT (10.7x cobertura).